WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway

Chenxu Ni(Second Military Medical University), Junping Zhang(Huaqiao University)
Oncotarget
October 22, 2016
Cited by 20


Related Papers